This session will explore the principles and practical application of partner notification when dealing with sexually transmitted infections (STIs) and identifying when partner notification is appropriate.
This session will discuss the links between sexually transmitted infections (STIs) and sexual problems before focusing on some basic aspects of management of patients with these issues.
This session looks at some definitions of sexual desire and arousal as well as the causes and management of absent or low sexual desire and arousal in women. It covers simple management and arranging onward referral for female patients with these problems
This session will cover chemsex related drugs, issues relating to chemsex and the basic approach to be taken with an individual presenting with a chemsex related drugs problem.
This session aims to aid understanding of the diversity of gender identity, thereby providing affirming sexual and reproductive healthcare for trans, non-binary, and intersex people.
This session explains what is meant by sensitivity and specificity of tests and how these translate into measures of positive predictive value and negative predictive value. The difference between diagnostic testing and screening for disease is discussed
This session describes how antigen and antibody tests are used to diagnose and manage sexually transmitted infections (STIs). The methodology, advantages and limitations of these tests are discussed with examples from clinical practice.
This session describes the common molecular methods used to diagnose sexually transmitted infections (STIs) in the UK, focusing on Chlamydia trachomatis (C. trachomatis) and N. gonorrhoeae as examples, to enable an understanding of the basic concepts and
